Roche announced positive one-year Phase III trial results for vamikibart, an investigational non-steroid treatment for uveitic macular edema (UME), showing sustained vision improvement and reduced macular swelling. The FDA has accepted Roche's Biologics License Application for vamikibart, with a decision expected by July 2027. If approved, it would be the first targeted non-steroid therapy for UME, offering a safer alternative to steroids that have significant side effects. Regulatory submissions are also underway in the EU, China, and Japan, highlighting the global potential of this treatment.
Roche's new Phase III data for vamikibart in uveitic macular edema is presented with Pluang's health sector market context as of Oct 11, 2026 04:41 WIB: Among 128 priced US health stocks, 109 rose and 18 fell. Notable movers include DFTX at USD 36.90 (+7.96%), IBRX at USD 10.51 (+6.05%), and CRSP at USD 53.39 (+5.85%).
At IAA TRANSPORTATION 2026 in Hanover, Winseed showcased key trends in automotive AI, emphasizing the shift from innovation to commercialization and the rising importance of AI-driven global brand visibility. Their research ranked 127 AI-related auto...
Rosen Law Firm has announced an investigation into possible breaches of fiduciary duties by Sprout Social's directors and officers. Investors holding Sprout Social stock are encouraged to contact the firm for more information and potential legal acti...
Microsoft CEO Satya Nadella emphasized the need for stronger safety measures in AI development, advocating for an 'emergency brake' that allows authorized users to pause or shut down AI models mid-task. He highlighted the importance of transparency b...
Rosen Law Firm is investigating claims that Beneficient may have provided misleading business information to investors. Shareholders who purchased Beneficient securities might be eligible for compensation through a class action lawsuit without upfron...
After a sharp Bitcoin price drop on October 7, large Bitcoin holders (whales) bought about 15,000 BTC worth $1.24 billion, signaling confidence in the market. Meanwhile, MARA, a major Bitcoin mining company, sold 996 BTC valued at $81 million to fund...
